Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
10/2006
10/17/2006US7122571 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/17/2006US7122570 Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)
10/17/2006US7122557 5-chloro-N-(5-chloropyridin-2-yl)-2-[(4-{(Z)-(dimethylamino)[(methylsulfonyl)imino]methyl}benzoyl)amino]benzamide; treating thromboembolic disorders, optionally with other active agents
10/17/2006US7122547 Anthranilic acid amides and the use thereof as medicaments
10/17/2006US7122538 Neuroleptic agents for treating schizophrenia, psychological disorders, depression; 5-(4-Chlorophenyl)-thiophene-2-sulfonic acid (8-methoxy-3-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)amide
10/17/2006US7122318 measuring integrin expression in platelets of a patient to which the drug (especially a sulfonamide) is administered and determining influence of it on integrin expression in cells other than platelets based on the measured expression amount.
10/17/2006CA2395705C Substituted phenyl-piperazine derivatives, their preparation and use
10/12/2006WO2006107035A1 Coloring matter for anisotropic coloring matter film, composition comprising said coloring matter, anisotropic coloring matter film, and polarizing element
10/12/2006WO2006106778A1 Bcrp/abcg2 inhibitor
10/12/2006WO2006106326A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
10/12/2006WO2006105796A1 Novel indolinone derivatives
10/12/2006WO2006105795A1 Novel indolinone derivatives
10/12/2006WO2006066879A3 Compounds with kv4 ion channel activity
10/12/2006WO2006047032A3 Indole compounds useful as serotonin selective agents
10/12/2006US20060229470 Calcium receptor-active molecules
10/12/2006US20060229311 Isatine derivatives with neurotrophic activity
10/12/2006US20060229298 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
10/12/2006US20060229296 1-[4-(2-Azepan-1-yl-ethoxy)-benzyl-2-(4-hydroxy-phenyl])-3-methyl-1H-indol-5-ol, or salts for treating bone loss
10/12/2006CA2602467A1 Bcrp/abcg2 inhibitor
10/12/2006CA2601983A1 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
10/11/2006EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006EP1710234A1 Malononitrile compound and use thereof
10/11/2006EP1709066A1 Inclusion complexes of perindopril
10/11/2006EP1709027A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
10/11/2006EP1709022A1 Selective estrogen receptor modulators
10/11/2006EP1709004A2 Pyrrole and pyrazole daao inhibitors
10/11/2006EP1708999A1 Bronchorelaxing compounds
10/11/2006EP1708998A1 Indol-alanine derivatives as selective s1p4-agonists
10/11/2006EP1708997A1 1-alkyl-3-thio-substituted indole-2-alkynoic acids useful for the treatment for alzheimer's disease and related conditions
10/11/2006EP1708996A1 Fused heteroyral derivatives for use as p38 kinase inhibitors
10/11/2006EP1708698A1 3-(4-piperidine-1ylmethyl-phenyl)-propion acid-phenylamide-derivatives and related compounds used in the form of mch antagonists (melanine concentrating hormone) for treating eating disorders
10/11/2006EP1551803B1 Azabicyclo derivatives as muscarinic receptor antagonists
10/11/2006EP1504022B1 Process for the synthesis of peptide amides by side-chain attachment to a solid phase
10/11/2006EP1469851B1 Melanocortin receptor agonists
10/11/2006EP1363903B1 Indole derivatives and their use as gnrh antagonists
10/11/2006CN1845898A Ppar活性化合物 Ppar active compounds
10/11/2006CN1844098A Process for synthesizing3-methyl-2-trifluoro methyl indole
10/11/2006CN1844097A 3-methyl-2-trifluoro methyl-N-(4-chloro benzoyl) indole
10/11/2006CN1844096A Preparation of mitiglinide calcium and its quality control method
10/11/2006CN1279042C 3-aryl-Beta-carboline-1-ketone compound, and its preparing method and use
10/11/2006CN1279023C Indole-3-sulphur derivatives
10/11/2006CN1279014C Vitamin A analogue derivative with antiangiogenic, antitumoral and proapoptotic activities
10/10/2006US7119214 dibenzofuranyl, dibenzothiophenyl or fluorenyl thioacetamides used for prophylaxis of sleep disorders
10/10/2006US7119209 Process for preparing indolinone derivatives
10/10/2006US7119204 phenanthroline compounds that exhibit electroluminescence, photoluminescence and/or photosensitivity, used in electrical apparatus such as organic light emitting diodes
10/10/2006US7119115 For therapy of treating tumors or cancerous cells
10/10/2006US7119105 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors
10/10/2006US7119093 3-Z-[1-(4-(N-((4-Methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composition
10/10/2006US7119090 Anticancer agents; antiinflammatory agents; autoimmune diseases; rheumatic diseases, enzyme inhibitors
10/10/2006US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer
10/10/2006US7118839 Charge transport compound containing at least two carbazolecarboxaldehyde substituted- hydrazone groups
10/10/2006CA2418778C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
10/10/2006CA2359046C Heterocyclically anellated indenochromene derivatives
10/10/2006CA2350734C 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof
10/05/2006WO2006104791A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
10/05/2006WO2006104221A1 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device
10/05/2006WO2006102760A1 Inhibitors of histone deacetylase
10/05/2006WO2006091972A3 Dimeric iap inhibitors
10/05/2006WO2006071609A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/05/2006WO2005027837A3 Substituted sulfonamides
10/05/2006WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators
10/05/2006US20060223890 N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
10/05/2006US20060223875 Methods and compositions for production, formulation and use of 1-aryl-3-azabicyclo[3.1.0]hexanes
10/05/2006US20060223842 such as (5-acetyl-1-methyl-1H-pyrrol-2-yl)acetyl methanesulphonamide, used for the of treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), skin disorders, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and reperfusion injuries after ischemia
10/05/2006US20060223827 Bioreductively activated stilbene prodrugs
10/05/2006US20060223826 Indole derivatives as somatostatin agonists or antagonists
10/05/2006US20060223784 Method and compositions for temporarily incapacitating subjects
10/05/2006DE102005015957A1 New substituted oxindole derivatives are vasopressin receptor binders useful to treat e.g. diabetes insipidus, enuresis nocturna, incontinence, hypertonia, heart failure, myocardial infarction, coronary spasm and renal disorders
10/05/2006CA2603589A1 Inhibitors of histone deacetylase
10/05/2006CA2601898A1 O-desmethylvenlafaxine and bazedoxifene combination product and uses thereof
10/04/2006EP1707560A1 Hydroxamic acid derivative and age generation inhibitor containing the derivative
10/04/2006EP1706396A1 N-(4-carbamimidoyl-benzyl)-2-alkoxy-2-heterocyclyl acetamides as inhibitors of the formation of coagulation factors xa, ixa and thrombin induced by factor viia
10/04/2006EP1706378A2 Process for crystallization of ramipril and preparation of a hydrated form thereof
10/04/2006EP1706377A1 Cis-alkoxyspiro-substituted tetramic acid derivatives
10/04/2006EP1706372A1 Alpha-hydroxy amides as bradykinin antagonists or inverse agonists
10/04/2006EP1706113A1 A process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2h-indol-2-one hydrochloride
10/04/2006EP1097382B1 Imidazoline receptor binding compounds
10/04/2006CN1842517A 芴衍生物 Fluorene derivatives
10/04/2006CN1842510A Fluorene-based derivative and organic electroluminescence device employing the same
10/04/2006CN1840607A Complexes of form l2mx as phosphorescent dopants for organic LEDs
10/04/2006CN1840530A Process for preparing pemetrexed
10/04/2006CN1277830C Para-herqueinamide as medicine for resisting parasite
10/04/2006CN1277828C Piperzine derivative
10/04/2006CN1277820C Phthalimido derivatives as inhibitors of monoamine oxidase B
10/03/2006US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006US7115753 Triaryl cation antibiotics from environmental DNA
10/03/2006US7115752 Substituted cyclic compounds
10/03/2006US7115751 Method for producing trimer of indole derivative, and trimer of indole derivative and laminated structure thereof
10/03/2006US7115750 Melanin concentrating hormone antagonist
10/03/2006US7115661 Methods and compositions for mitigating pain
10/03/2006US7115648 use for treating type 2 diabetes, insulin resistance, syndrome X, hyperinsulinaemia, hyperglucagonaemia, cardiac ischaemia and obesity
10/03/2006US7115628 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction
10/03/2006US7115627 Trypsin-like serine protease enzyme inhibitors; anticoagulants
10/03/2006US7115618 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
10/03/2006US7115613 Compound of fused nitrogen containing heterocyclic ring, useful for treating prostate and angiogenic disorders
10/03/2006US7115607 Substituted piperazinyl amides and methods of use
10/03/2006US7115600 Histamine-3 receptor modulators
10/03/2006US7115541 Catalyst comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalyst
10/03/2006US7115412 Process for the preparation of optically active 7-substituted-3-(2-aminopropyl)indole derivatives and intermediates therefor
10/03/2006US7115401 Using hydrophobic fluorescent ion capable of redistributing from a first face of the membrane to a second face of the membrane in response to changes in the membrane potential